Skip to content
← Back to this collection

PUBLICATIONS · 19114685

A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2009 Feb 10
First author
Hecht JR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Feb 10;27(5):655-8. doi: 10.1200/JCO.2008.21.2522.
    note
    Source null
    related pmid
    19114682
    relationship
    Comment in
  2. citation
    Immunotherapy. 2009 May;1(3):339-40.
    note
    Source null
    related pmid
    20653090
    relationship
    Comment in

Authors and identifiers

  1. name
    Hecht JR
    type
    Author
  2. name
    Mitchell E
    type
    Author
  3. name
    Chidiac T
    type
    Author
  4. name
    Scroggin C
    type
    Author
  5. name
    Hagenstad C
    type
    Author
  6. name
    Spigel D
    type
    Author
  7. name
    Marshall J
    type
    Author
  8. name
    Cohn A
    type
    Author
  9. name
    McCollum D
    type
    Author
  10. name
    Stella P
    type
    Author
  11. name
    Deeter R
    type
    Author
  12. name
    Shahin S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Hecht JR
    type
    Author
  2. name
    Mitchell E
    type
    Author
  3. name
    Chidiac T
    type
    Author
  4. name
    Scroggin C
    type
    Author
  5. name
    Hagenstad C
    type
    Author
  6. name
    Spigel D
    type
    Author
  7. name
    Marshall J
    type
    Author
  8. name
    Cohn A
    type
    Author
  9. name
    McCollum D
    type
    Author
  10. name
    Stella P
    type
    Author
  11. name
    Deeter R
    type
    Author
  12. name
    Shahin S
    type
    Author
bibliography ids
  1. nci-bib-488c51186f2c740e348170d2
book metadata
content sha256
3ff088f68683e2b53ad462c2cb418daa3dc96ceb4452a94b20a67ce99aa2f289
document type
citation
dois
  1. 10.1200/JCO.2008.19.8135
electronic publication date
display
2008 Dec 29
precision
day
year
2008
evidence scope
bibliographic_metadata_only
id
pubmed:19114685
immutable id
pubmed:19114685@3ff088f68683e2b53ad462c2cb418daa3dc96ceb4452a94b20a67ce99aa2f289
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
5
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
672-80
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2009 Feb 10;27(5):655-8. doi: 10.1200/JCO.2008.21.2522.
    note
    Source null
    related pmid
    19114682
    relationship
    Comment in
  2. citation
    Immunotherapy. 2009 May;1(3):339-40.
    note
    Source null
    related pmid
    20653090
    relationship
    Comment in
outcomes validated
false
pmid
19114685
provenance
batch id
27a383f06e5fc3d04fad
provider
NCBI PubMed ESummary
record sha256
2feab6e0b03ac191a7e9a0707aa5e413d0580bd3d3b2c13094ee941e00cf4180
response sha256
51f0f2a142dbd9b135e872b049b116f51941299445a5416feae10f12fac8d978
retrieved at
2026-09-09T23:46:24.265787+00:00
publication date
display
2009 Feb 10
precision
day
year
2009
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19114685/
title
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.

Preserved source evidence · Independent clinical review pending · Not medical advice